Free AE-Adult-Echocardiography Questions Attempt

The color Doppler image in the four-chamber view shows a jet across the interatrial septum, indicating a shunt at the atrial level. In a patient with left atrial enlargement, the most common incidental finding causing such flow is a patent foramen ovale (PFO). A PFO is a small communication between the right and left atria that can open under certain pressure conditions, leading to shunting.

Muscular ventricular septal defect is a ventricular level defect and would be seen in different views. Coronary-cameral fistula is a rare anomaly involving abnormal connections between coronary arteries and cardiac chambers, not typical in this setting. Sinus venosus defect is an atypical atrial septal defect located near the superior vena cava and would require different imaging planes for detection.

This finding and its implications are discussed in the "Textbook of Clinical Echocardiography, 6e", Chapter on Atrial Septal Defects and Shunts【20:115-120†Textbook of Clinical Echocardiography】.

The continuity equation calculates aortic valve area (AVA) by equating stroke volume through the left ventricular outflow tract (LVOT) to stroke volume through the aortic valve. The equation is:

AVA = (Cross-sectional area of LVOT) × (LVOT VTI) / (Aortic valve VTI)

The cross-sectional area of the LVOT is derived from the LVOT diameter, using the formula π × (diameter/2)^2. Because the diameter is squared in this calculation, even a small error in measurement leads to a significant error in the calculated valve area.

This makes the LVOT diameter measurement the greatest source of error when calculating AVA by the continuity equation. Errors in Doppler velocity measurements (LVOT velocity or aortic jet velocity) are also important but less impactful compared to diameter measurement error.

Aortic valve planimetry is a direct measurement method, not part of the continuity equation. LVOT velocity recorded with pulsed Doppler and aortic jet velocity by continuous wave Doppler are important but not the greatest error source.

This is a well-established concept described in the "Textbook of Clinical Echocardiography, 6e", Chapter on Valvular Stenosis and Continuity Equation Methodology【20:370-375†Textbook of Clinical Echocardiography】.

The video shows thickened, retracted, and possibly regurgitant valve leaflets with a characteristic appearance seen in drug-induced valvulopathy. Drugs such as ergot derivatives (e.g., methysergide) and appetite suppressants (e.g., fen-phen) can cause fibrotic thickening of valve leaflets mimicking carcinoid heart disease or rheumatic valve disease.

Infective endocarditis presents with vegetations and potentially valve destruction but typically not the diffuse thickening seen here. Rheumatic fever causes leaflet thickening but has a different chronic clinical course. Systemic lupus may cause valve thickening but often involves Libman-Sacks vegetations rather than diffuse fibrosis.

This is discussed in the "Textbook of Clinical Echocardiography, 6e", Chapter on Valvular Heart Disease - Drug Induced and Secondary Causes【20:400-405†Textbook of Clinical Echocardiography】.

The Valsalva maneuver decreases preload and left ventricular volume, which exacerbates left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy (HOCM). This results in an increase in the gradient and severity of obstruction and symptoms during the maneuver.

Aortic valve stenosis, aortic regurgitation, and mitral regurgitation typically decrease or do not significantly change during Valsalva because of decreased flow and pressure.

This physiological response is detailed in the "Textbook of Clinical Echocardiography, 6e", Chapter on Dynamic Left Ventricular Outflow Obstruction and Maneuvers【20:370-375†Textbook of Clinical Echocardiography】.